Maynard Um
-
-
-
-
-
-
-
Galmed to present cancer research at HEP-DART 2025 conference
-
-
-
-
-
-
-
Galmed Pharma (GLMD) Reports Q1 Loss of $0.62
-
-
-
-
405,209 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

